MUMBAI, India, and NAPLES, Fla., July 28, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval under the Federal Food, Drug, and… For the full story, visit the source.
BusinessMaharashtra
Lupin Announces the Approval of Diazepam Injection, USP in the United States
MUMBAI, India, and NAPLES, Fla., July 28, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval under the Federal Food, Drug, and…
PRNewswire· 2 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire